MJ News and Press, ETFMG Alternative Harvest From 02/17/23

Best Marijuana Stocks For Investors In 2023 Do you intend to invest for the long run in the top marijuana stocks ? At the present time, finding long-term investments with a general sense of stability may be challenging, given the market volatility linked with the top cannabis stocks to wa...

Summary Cannabis stocks are really cheap, but Alan Brochstein is worried about 3 things. Thoughts on Cresco/Columbia Care deal. Sector debt and optimal cannabis investing metrics. Canadian and US operators. Concerns around MSOS; limitations of ETFs. Why Alan's 19% in cash. ...

Summary Nick Gastevich, aka CannaVestments, one of our favorite commenters on Seeking Alpha, returns for a super actionable take on cannabis stocks. Focus on companies that control their own destinies as much as possible. Which balance sheets are in trouble and who's generating real...

Summary ETFMG Alternative Harvest (MJ) has some unusual qualities that distinguish it from other cannabis ETFs. MJ has outperformed other ETFs in its sector. A deep dive into MJ reveals why it has outperformed. The cannabis ETFs and MJ Most of the attention cannabis receiv...

Cannabis stocks had a rough time over the past year, with the EFT Alternative Harvest ETF (NYSEMKT: MJ) and the AdvisorShares Pure Cannabis ETF (NYSEMKT: YOLO) down by more than 53% and 64%, respectively. A glut of cannabis and falling revenues were the most obvious reasons fo...

Are These The Best Cannabis Stocks To Invest in For Your Long-Term Portfolio? Do you aim to make long-term investments in the best marijuana stocks ? In general, given the market volatility associated with the best cannabis stocks to follow, finding long-term investments with a general se...

It can be hard for investors to see anything good in the cannabis space through all the smoke of 2022's collapsing share prices. The AdvisorShares Pure Cannabis ETF (NYSEMKT: MSOS) is down more than 70% over the past year, while the ETFMG Alternative Harvest ETF (NYSEMKT: MJ) is d...

Summary InterCure earned CAD$39 million in Q3 2022, up 61.2% from the previous year. Moreover, at the end of Q4 2022, the total number of licensed patients using cannabis for medical purposes in Israel was 123,212, up 13,860 from the previous year. Currently, the cannabis industry c...

Summary The most consistent progress in cannabis is coming from states continuing to roll out legalization programs. For cannabis companies wanting to make a profit in these legal markets, there is both opportunity and a need to navigate growing pains. A reminder from Tim Seymo...

The stock market hasn't performed well over the past year, and cannabis stocks have been in the crosshairs for bearish investors. The pain has been widespread across the marijuana industry, with the ETFMG Alternative Harvest ETF (NYSEMKT: MJ) having lost more than half its value just sinc...